InvestorTransforming businesses for long-term success.

Ajinomoto Group Ventures (AGV) is the corporate venture capital arm of Ajinomoto Co., Inc., focusing on investments in global startups within healthcare, ICT, food and wellness, and green technology. Established in 2020, AGV operates from offices in Burlingame, Tokyo, and Palo Alto.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Ajinomoto Group Ventures (AGV) is the corporate venture capital arm of Ajinomoto Co., Inc., a leading Japanese company in amino science founded in 1909. AGV was established in December 2020 and has since focused on investing in early-stage companies that align with Ajinomoto's expertise in healthcare, ICT, food and wellness, and green technology. With a fund size of approximately $100M, AGV aims to back transformative companies that leverage Ajinomoto's deep knowledge in amino acids, fermentation, and food science. The organization operates globally, with a primary focus on North America, Asia, and EMEA, and has offices in Burlingame, CA, and Tokyo.
AGV targets investments primarily in early-stage companies, particularly in Series A rounds, across sectors such as healthcare (including gene therapy and regenerative medicine), ICT (optics and advanced materials), food & wellness, and green technologies (fermentation and agrifood sustainability). The fund emphasizes strategic partnerships and co-investments with institutional VCs.
AGV provides strategic value to its portfolio companies by leveraging Ajinomoto's extensive expertise in amino acids, fermentation, and food science, as well as its global distribution networks and supply chains. This synergy enhances the potential for innovation and market success for its investments.
Superscout Pro
Is this page right?Reviewed · How the research works